These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The role of benznidazole with cyanocobalamin and ascorbic acid in treating the chronic phase of Chagas disease. Ghobadifar MA; Kalani N; Gitiforouz M; Mosallanejad Z Rev Soc Bras Med Trop; 2014; 47(5):669. PubMed ID: 25467275 [No Abstract] [Full Text] [Related]
5. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity. Zingales B; Miles MA; Moraes CB; Luquetti A; Guhl F; Schijman AG; Ribeiro I; ; Mem Inst Oswaldo Cruz; 2014 Sep; 109(6):828-33. PubMed ID: 25317712 [TBL] [Abstract][Full Text] [Related]
6. In Vitro Image-Based Assay for Trypanosoma cruzi Intracellular Forms. Eufrásio AG; Cordeiro AT Methods Mol Biol; 2020; 2116():773-780. PubMed ID: 32221954 [TBL] [Abstract][Full Text] [Related]
7. Infectious diseases. Drug developers finally take aim at a neglected disease. Leslie M Science; 2011 Aug; 333(6045):933-5. PubMed ID: 21852468 [No Abstract] [Full Text] [Related]
8. A new chemotype with promise against Trypanosoma cruzi. Wang X; Cal M; Kaiser M; Buckner FS; Lepesheva GI; Sanford AG; Wallick AI; Davis PH; Vennerstrom JL Bioorg Med Chem Lett; 2020 Jan; 30(1):126778. PubMed ID: 31706668 [TBL] [Abstract][Full Text] [Related]
9. Parasitological cure of Chagas disease: is it possible? Is it relevant? Urbina JA Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():349-55. PubMed ID: 10677754 [No Abstract] [Full Text] [Related]
10. [Experimental study on the therapeutic action of Ro 7-1051 on infections caused by different strains of Trypanosoma cruzi]. Andrade SG; Figueira RM Rev Inst Med Trop Sao Paulo; 1977; 19(5):335-41. PubMed ID: 416483 [No Abstract] [Full Text] [Related]
11. A flow cytometer-based method to simultaneously assess activity and selectivity of compounds against the intracellular forms of Trypanosoma cruzi. Miranda CG; Solana ME; Curto MLA; Lammel EM; Schijman AG; Alba Soto CD Acta Trop; 2015 Dec; 152():8-16. PubMed ID: 26272680 [TBL] [Abstract][Full Text] [Related]
12. New leads for trypanosomiasis chemotherapy. Lancet; 1978 Dec; 2(8101):1190. PubMed ID: 82152 [No Abstract] [Full Text] [Related]
13. Translational challenges of animal models in Chagas disease drug development: a review. Chatelain E; Konar N Drug Des Devel Ther; 2015; 9():4807-23. PubMed ID: 26316715 [TBL] [Abstract][Full Text] [Related]
14. Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery. Mansoldo FRP; Carta F; Angeli A; Cardoso VDS; Supuran CT; Vermelho AB Molecules; 2020 Nov; 25(22):. PubMed ID: 33238613 [TBL] [Abstract][Full Text] [Related]
15. Discovery and Optimization of a Compound Series Active against Harrison JR; Sarkar S; Hampton S; Riley J; Stojanovski L; Sahlberg C; Appelqvist P; Erath J; Mathan V; Rodriguez A; Kaiser M; Pacanowska DG; Read KD; Johansson NG; Gilbert IH J Med Chem; 2020 Mar; 63(6):3066-3089. PubMed ID: 32134269 [TBL] [Abstract][Full Text] [Related]
16. The urgent need to develop new drugs and tools for the treatment of Chagas disease. Muñoz MJ; Murcia L; Segovia M Expert Rev Anti Infect Ther; 2011 Jan; 9(1):5-7. PubMed ID: 21171870 [No Abstract] [Full Text] [Related]